Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xueqiang Gao

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Breast Cancer (Tokyo, Japan)|April 17, 2019
PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activationXueqiang Gao, Xiangping Liu, Yangyong Lu, et al.
BMC Cancer|December 30, 2025
Identification of RPGRIP1L as an instability-maintaining gene to drive tumor growth and PD-L1 expression via Hedgehog signaling in breast cancerMeng Lv, Yan'e Liu, Weihong Cao, et al.
Frontiers in Oncology|March 12, 2025
Deep learning model for the early prediction of pathologic response following neoadjuvant chemotherapy in breast cancer patients using dynamic contrast-enhanced MRIMeng Lv, BinXin Zhao, Yan Mao, et al.
Nanoscale|February 24, 2018
A novel IrNi@PdIr/C core-shell electrocatalyst with enhanced activity and durability for the hydrogen oxidation reaction in alkaline anion exchange membrane fuel cellsBowen Qin, Hongmei Yu, Jia Jia, et al.
Cell Biology International|December 2, 2021
Augmentation of antitumor function of tumor-infiltrating lymphocytes against triple-negative breast cancer by PD-1 blockadeHongming Song, Haibo Wang, Mingkai Gong, et al.
RSC Advances|May 11, 2022
3D Pd/Co core-shell nanoneedle arrays as a high-performance cathode catalyst layer for AAEMFCsJia Jia, Hongmei Yu, Xueqiang Gao, et al.
Frontiers in Oncology|July 24, 2025
A real-world study of palbociclib plus endocrine therapy with or without a short course chemotherapy in the first-line treatment of HR-positive HER2-negative metastatic breast cancerXiangjun Li, Yuhua Song, Meng Lv, et al.
Frontiers in Oncology|June 27, 2022
Efficacy and Safety of Mitoxantrone Hydrochloride Injection for Tracing Axillary Sentinel Nodes in Breast Cancer: A Self-Controlled Clinical TrialDechuang Jiao, Benlong Yang, Jiajian Chen, et al.
BMC Cancer|May 27, 2025
Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in ChinaBenlong Yang, Zhengkui Sun, Quchang Ouyang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Breast Cancer (Tokyo, Japan)|April 17, 2019
PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activationXueqiang Gao, Xiangping Liu, Yangyong Lu, et al.
BMC Cancer|December 30, 2025
Identification of RPGRIP1L as an instability-maintaining gene to drive tumor growth and PD-L1 expression via Hedgehog signaling in breast cancerMeng Lv, Yan'e Liu, Weihong Cao, et al.
Frontiers in Oncology|March 12, 2025
Deep learning model for the early prediction of pathologic response following neoadjuvant chemotherapy in breast cancer patients using dynamic contrast-enhanced MRIMeng Lv, BinXin Zhao, Yan Mao, et al.
Nanoscale|February 24, 2018
A novel IrNi@PdIr/C core-shell electrocatalyst with enhanced activity and durability for the hydrogen oxidation reaction in alkaline anion exchange membrane fuel cellsBowen Qin, Hongmei Yu, Jia Jia, et al.
Cell Biology International|December 2, 2021
Augmentation of antitumor function of tumor-infiltrating lymphocytes against triple-negative breast cancer by PD-1 blockadeHongming Song, Haibo Wang, Mingkai Gong, et al.
RSC Advances|May 11, 2022
3D Pd/Co core-shell nanoneedle arrays as a high-performance cathode catalyst layer for AAEMFCsJia Jia, Hongmei Yu, Xueqiang Gao, et al.
Frontiers in Oncology|July 24, 2025
A real-world study of palbociclib plus endocrine therapy with or without a short course chemotherapy in the first-line treatment of HR-positive HER2-negative metastatic breast cancerXiangjun Li, Yuhua Song, Meng Lv, et al.
Frontiers in Oncology|June 27, 2022
Efficacy and Safety of Mitoxantrone Hydrochloride Injection for Tracing Axillary Sentinel Nodes in Breast Cancer: A Self-Controlled Clinical TrialDechuang Jiao, Benlong Yang, Jiajian Chen, et al.
BMC Cancer|May 27, 2025
Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in ChinaBenlong Yang, Zhengkui Sun, Quchang Ouyang, et al.
Pageof 1